ESMO 2023 – GSK sets up Pfizer battle in B7-H4
Early data on Hansoh’s HS-20089 were enough to tempt GSK, but Seagen isn't far behind.
Early data on Hansoh’s HS-20089 were enough to tempt GSK, but Seagen isn't far behind.
